Results 31 to 40 of about 147,480 (239)

Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF‐TIMI 48 Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Epistaxis is common with antithrombotic therapy and is often troublesome to patients, yet its frequency, severity, and outcomes are poorly characterized.
Robert S. Semco   +9 more
doaj   +1 more source

Stroke following percutaneous coronary intervention : type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12 [PDF]

open access: yes, 2016
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015.
Berry, Colin   +11 more
core   +1 more source

Hurdles in stroke thrombolysis: Experience from 100 consecutive ischemic stroke patients

open access: yesAnnals of Indian Academy of Neurology, 2015
Background: Acute management of ischemic stroke involves thrombolysis within 4.5 h. For a successful outcome, early recognition of stroke, transportation to the hospital emergency department immediately after stroke, timely imaging, proper diagnosis, and
Sagar Badachi   +4 more
doaj   +1 more source

No space Left for Intravenous thrombolysis in acute stroke [PDF]

open access: yes, 2016
Recent successful clinical trials of endovascular thrombectomy for large artery ischaemic stroke have established the value of this treatment modality as an adjunct to intravenous thrombolysis, not as an alternative: thrombectomy delivery was undertaken ...
Muir, Keith
core   +1 more source

Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch [PDF]

open access: yes, 2017
Background: Diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) mismatch was suggested to identify stroke patients with unknown time of symptom onset likely to be within the time window for thrombolysis. Aims: We aimed
Boutitie, Florent   +18 more
core   +2 more sources

Time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke

open access: yesJournal of the Formosan Medical Association, 2015
Background/Purpose: Intravenous thrombolysis for ischemic stroke saves societal costs. The aim of this study was to investigate the cost burden that hospitals may shoulder.
Mu-Chien Sun, Pi-Ju Hsiao
doaj   +1 more source

Stroke with unknown time of symptom onset: baseline clinical and magnetic resonance imaging data of the first thousand patients in WAKE-UP (efficacy and safety of mri-based thrombolysis in wake-up stroke: a randomized, doubleblind, placebo-controlled trial) [PDF]

open access: yes, 2017
Background and Purpose—We describe clinical and magnetic resonance imaging (MRI) characteristics of stroke patients with unknown time of symptom onset potentially eligible for thrombolysis from a large prospective cohort.
Boutitie, Florent   +18 more
core   +2 more sources

Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism

open access: yesPulmonary Circulation, 2020
Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications.
David Antoine   +6 more
doaj   +1 more source

Choices Regarding Thrombolysis Are Modified by the Way to Transfer the Messages

open access: yesFrontiers in Neurology, 2017
Although thrombolysis is the most effective medical treatment for acute ischemic stroke, many stroke patients eligible for thrombolysis miss this treatment as a result of delay or refusal by the patients and/or their proxies. To explore the influences of
Jingjing Gong   +6 more
doaj   +1 more source

Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis [PDF]

open access: yes, 2007
Objective: To assess the cost effectiveness of primary angioplasty, compared with medical management with thrombolytic drugs, to achieve reperfusion after acute myocardial infarction ( AMI) from the perspective of the UK NHS.
Abrams, Keith   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy